1. Home
  2. FMS vs ARCC Comparison

FMS vs ARCC Comparison

Compare FMS & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMS
  • ARCC
  • Stock Information
  • Founded
  • FMS 1996
  • ARCC 2004
  • Country
  • FMS Germany
  • ARCC United States
  • Employees
  • FMS N/A
  • ARCC N/A
  • Industry
  • FMS Misc Health and Biotechnology Services
  • ARCC Finance/Investors Services
  • Sector
  • FMS Health Care
  • ARCC Finance
  • Exchange
  • FMS Nasdaq
  • ARCC Nasdaq
  • Market Cap
  • FMS 15.9B
  • ARCC 15.5B
  • IPO Year
  • FMS 1996
  • ARCC 2004
  • Fundamental
  • Price
  • FMS $28.46
  • ARCC $21.87
  • Analyst Decision
  • FMS Hold
  • ARCC Buy
  • Analyst Count
  • FMS 1
  • ARCC 9
  • Target Price
  • FMS $30.00
  • ARCC $22.25
  • AVG Volume (30 Days)
  • FMS 395.6K
  • ARCC 4.4M
  • Earning Date
  • FMS 07-29-2025
  • ARCC 07-29-2025
  • Dividend Yield
  • FMS 1.99%
  • ARCC 8.74%
  • EPS Growth
  • FMS 27.83
  • ARCC N/A
  • EPS
  • FMS 2.28
  • ARCC 2.04
  • Revenue
  • FMS $21,068,786,202.00
  • ARCC $3,021,000,000.00
  • Revenue This Year
  • FMS $2.74
  • ARCC $2.84
  • Revenue Next Year
  • FMS $3.60
  • ARCC $5.66
  • P/E Ratio
  • FMS $25.09
  • ARCC $10.79
  • Revenue Growth
  • FMS 0.10
  • ARCC 12.01
  • 52 Week Low
  • FMS $17.93
  • ARCC $18.26
  • 52 Week High
  • FMS $30.46
  • ARCC $23.84
  • Technical
  • Relative Strength Index (RSI)
  • FMS 51.55
  • ARCC 52.15
  • Support Level
  • FMS $26.16
  • ARCC $21.37
  • Resistance Level
  • FMS $28.23
  • ARCC $21.70
  • Average True Range (ATR)
  • FMS 0.35
  • ARCC 0.28
  • MACD
  • FMS -0.10
  • ARCC -0.06
  • Stochastic Oscillator
  • FMS 63.92
  • ARCC 40.85

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About ARCC Ares Capital Corporation

Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.

Share on Social Networks: